Abstract:OBJECTIVE:To explore the antimicrobial resistance of nosocomial Gram-negative bacilli across China. METHODS:A total of 1247 consecutive and non-repetitive Gram-negative bacilli were isolated from 13 Chinese teaching hospitals from March to August 2012. All isolates were sent to a central laboratory for reidentification and susceptibility testing. The minimal inhibitory concentration (MICs) of meropenem and other antibacterial agents were determined by agar dilution method. And the data were analyzed with WHONET-5.6 software. RESULTS:The activity of antimicrobial agents against Enterobacteriaceae was in the following descending order of susceptibility rate: meropenem (97.5%, 849/871) , amikacin (94.5%, 823/871) , imipenem (93.6%, 815/871) , ertapenem (92.9%, 809/871) , piperacillin/tazobactam (89.9%, 783/871) , cefoperazone/sulbactam (83.5%, 727/871) , cefepime (78.1%, 680/871) , polymyxin B (77.0%, 670/871) , cefiazidime (69.6%, 606/871) , levofloxacin (69.2%, 603/871) , ciprofloxacin (63.6%, 554/871) , minocyline (63.1%, 550/871) , ceftriaxone (55.7%, 485/871) , cefotaxime (54.2%, 472/871) and cefoxitin (51.4%, 448/871) . The prevalence of extended-spectrum beta-lactamase (ESBL) was 64.3% (117/182) in Escherichia coli (E. coli) and 32.1% (60/187) in Klebsiella pneumonia (K. pneumoniae) . The sensitivities of E. coli to meropenem and imipenem were 100%. And over 90% of E. coli was sensitive to ertapenem, amikacin, piperacillin/tazobactam and polymyxin B. However, over 60% of E. coli was resistant to ciprofloxacin, levofloxacin, ceftriaxone and cefotaxime. The susceptibility of K. pneumoniae to meropenem, imipenem, amikacin and polymyxin B maintained at over 90%. The activities of antimicrobial agents against E. cloacae, E. aerogenes and Citrobacter freundii were in the following descending order of susceptibility rate: meropenem (96.0%-100%) , imipenem (96.0%-100%) , polymyxin B (95.8%-100%) , amikacin (92.2%-100%) , ertapenem (85.6%-93.3%) , cefepime (77.8%-93.3%) , cefoperazone/sulbactam (78.4%-90.0%) and piperacillin/tazobactam (65.0%-89.8%) . The most susceptible agent against Acinetobacter baumannii (A. baumannii) was polymyxin B (100%) . The susceptibilities of A.baumannii to imipenem, meropenem and minocyline were 37.8% (65/172) , 36.0% (62/172) and 62.8% (108/172) respectively. The most active agents against Pseudomonas aeruginosa (P. aeruginosa) were polymyxin B (97.2%, 173/178) , followed by amikacin (89.3%, 159/178) and cefiazidime (83.7%, 149/178) . Clinical and Laboratory Standards Institute revised P.aeruginosa susceptibility standard in 2012. The sensitivity of piperacillin/tazobactam changed from 83.7% (149/178) to 77.5% (138/178) . The sensitivity of meropenem decreased from 78.1% ( 139/178 ) to 71.3% ( 127/178 ) while that of imipenem declined from 69.7% (124/178) to 59.6% (106/178) . The prevalence of multi-drug resistant A. baumannii and P. aeruginosa were 65.7% (113/172) and 9.0% (16/178) respectively. CONCLUSIONS:Carbapenems remain highly active against Enterobacteriaceae. Increasing resistance of A. baumannii to all antimicrobial agents is noted. New breakpoint to P.aeruginosa has obvious effects on antimicrobial sensitivity.

Changing antibiotic resistance pattern of clinical isolates in a teaching hospital

Surveillance of antibiotic resistance in clinical isolates from First Affiliated Hospital of Zhejiang University Medical College in 2009

[Surveillance of Antimicrobial Resistance among Nosocomial Gram-Negative Pathogens from 15 Teaching Hospitals in China in 2005].

Antimicrobiai Resistance Surveillance on Hospital-and Community-acquired Pathogens in 10 Teaching Hospitals in China

Distribution and Resistance of Clinical Pathogenic Bacterial Isolates in Our Hospital 2005-2007

Mohnarin Report of 2011 : Monitoring of Bacterial Resistance in Central-Southern China

Distribution and change in drug resistance of clinical isolates in a hospital from 2006 to 2008

Variation in resistance of beta-lactam antibiotics against bacterial pathogens during 2001～2005

Clinical Distribution and Drug Resistance of Pathogens Causing Nosocomial Infection Isolated from 2005 to 2009

Bacterial Distribution and the Surveillance of Its Resistance to Antimicrobial Agents

Research of Pseudomonas aeruginosa and Escherichia coli resistance changes in recent 5 years

Drug resistant changing of Staphylococcus aureus from the years of 2006 to 2011

Changes of distribution and drug resistance of pathogens isolated from blood culture in hematology department wards from 2006 to 2015

Changes of pathogens and antibiotic susceptibility surveillance in a respiratory ward from 2001 to 2005

Surveillance of antibiotic resistance in clinical isolates from peking union medical college hospital during 2009

Analysis of Bacterial Drug Resistance Changes in Our Hospital During 2001～2005

Changing resistance proifle ofProteus, Serratia, Citrobacter, Morganella andProvidencia isolates in hospitals across China：data from CHINET Antimicrobial Resistance Surveillance Program 2005-2014

Analysis of Susceptibility Trend of Main Pathogen to Antibiotics in Our Hospital

[Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].

Changing pattern of bacterial resistance in Gram negative bacilli

Change of bacterial pathogens and resistance rates in lower respiratory tract infection during recent 12 years